Pycnogenol attenuates thioacetamide-induced neurobehavioral impairment and hepatotoxicity via multi-target molecular modulation.

Although TAA administration tended to increase serum TOS, TNF-α, and IL-1β levels and decrease TAS levels, and PYC treatment tended to partially normalize these alterations, the differences among groups did not reach statistical significance.

also in 111,027 other papers